ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,741Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 1155

$351K Total Retail Price of All Prescriptions

Rank: 165 out of 1155

301 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 301 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

25% of this provider’s 301 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 6,362 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 427 325 S3 1 4
OMEPRAZOLE 346 269 2 5
LEVOTHYROXINE SODIUM 322 278 3 2
PRAVASTATIN SODIUM 264 251 4 20
FUROSEMIDE 211 201 5 8
CITALOPRAM HBR 204 142 6 19
METFORMIN HCL 193 181 7 7
LISINOPRIL 191 161 8 1
AMLODIPINE BESYLATE 190 180 9 6
POTASSIUM CHLORIDE 176 171 10 16
ATENOLOL 153 137 11 10
GABAPENTIN 146 68 12 15
TRAMADOL HCL 138 112 13 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 121 14 26
WARFARIN SODIUM 104 102 15 11
METOPROLOL TARTRATE 101 93 16 14
OXYCODONE HCL 100 48 S2 17 23
FAMOTIDINE 91 74 18 76
ZOLPIDEM TARTRATE 86 59 19 21
METOPROLOL SUCCINATE 82 73 20 17
HYDROCHLOROTHIAZIDE 81 71 21 9
KLOR-CON 10 80 67 22 108
ALLOPURINOL 80 75 22 29
ATORVASTATIN CALCIUM 74 67 24 12
AMITRIPTYLINE HCL 71 34 R 25 42
TRAZODONE HCL 70 44 26 22
TAMSULOSIN HCL 65 54 27 27
GLIPIZIDE 63 61 28 44
ESTRADIOL 62 56 R 29 60
SIMVASTATIN 62 57 29 3
DIGOXIN 61 61 31 54
BUPROPION XL 56 44 32 139
PROAIR HFA 54 36 33 31
BUMETANIDE 54 52 33 143
FLUOXETINE HCL 52 40 35 30
DOXAZOSIN MESYLATE 50 50 36 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.